The incidence of brain metastases from hepatocellular carcinoma (BMHCC) is becoming
more frequent than that of the past as a result of prolonged survival of patients with HCC …

The proper treatment of brain metastases continues to be a challenge for oncologists given
the variability of individual patients' prognoses and the variety of treatment options available …

Hepatocellular carcinoma (HCC) is a common malignancy with high mortality, especially in
HCC patients with brain metastases (BMS). However, few studies have investigated the risk …

The incidence of brain metastasis from hepatocellular carcinoma (HCC) is increasing
because of the improved survival outcome of HCC patients, but the prognosis of these …

Purpose Intracerebral metastases present a substantial risk of tumor-associated
intracerebral hemorrhage (ICH). This study aimed to investigate the risk of hemorrhagic …

Background Brain metastasis is a rare event in patients with hepatocellular carcinoma
(HCC). This retrospective study aimed to identify the prognostic factors and determine the …

Objective: To establish a prognostic model for overall survival prediction in patients with
hepatocellular carcinoma (HCC) treated with external beam radiotherapy (RT) for lymph …

Background Brain metastases from hepatocellular carcinoma (HCC) are rare, but their
incidence is increasing because of developments in recent therapeutic advances. The …

Background: This study aimed to identify the incidence, risk factors, and survival outcome
associated with brain metastases (BM) in hepatocellular carcinoma (HCC) patients using a …

Introduction The introduction of systemic chemotherapy for advanced hepatocellular
carcinoma in recent years has led to the prediction that cases of brain metastases from …